Factors Associated With Short-Term Major Adverse Cardiovascular Events After Liver Transplantation

Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY

Cardiovascular disease has become the leading cause of death early after liver transplantation (LT). The aging LT population is accompanied with the increasing prevalence of cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia. Furthermore, cirrhosis has been known to cause alterations in the systemic haemodynamic system and cardiac muscle dysfunction, systolic and/or diastolic, known as Cirrhotic cardiomyopathy (CCM). Hence, transthoracic echocardiography is required in all LT candidates for preprocedural evaluation and risk stratification. However, traditional echocardiographic indices of cardiac function have low sensitivity. It is unclear whether comprehensive echocardiographic multiparameters, including speckle tracking echocardiograph (STE) and tissue doppler imaging (TDI) can help improve preoperative risk stratification. Therefore, we sought to analyze the ability of clinical and comprehensive echocardiography variables to predict intraoperative and perioperative cardiac events and cardiac mortality in our LT patient experience up to early post-liver transplant.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age \> 18 years,

• End-stage cirrhosis patients who will receive liver transplantation,

• Patients voluntarily take part in the study and write informed consent.

Locations
Other Locations
China
the Third Affiliated Hospital of Sun Yat-sen University
RECRUITING
Guangzhou
The Third Affiliated Hospital of Sun Yat-sen University
RECRUITING
Guangzhou
Contact Information
Primary
Jia Liu, Dr
395847953@qq.com
15920190962
Backup
Jie Ren, Dr
renj@mail.sysu.edu.cn
13925155583
Time Frame
Start Date: 2024-04-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 200
Sponsors
Leads: Sun Yat-sen University

This content was sourced from clinicaltrials.gov